See the DrugPatentWatch profile for human
What is recombinant human hyaluronidase?
Recombinant human hyaluronidase is an enzyme therapy designed to break down hyaluronic acid, a major component of the body’s extracellular matrix. By degrading hyaluronic acid, it can help improve spread or absorption of administered substances in targeted clinical contexts.
What is recombinant human hyaluronidase used for?
It is used where breaking down hyaluronic acid is beneficial for treatment delivery or local tissue effects. In practice, hyaluronidase products are commonly used as an adjunct to increase dispersion of injected medicines, which can improve effectiveness and reduce localization issues from the injection site.
How does it work compared with other hyaluronidase products?
Recombinant human hyaluronidase is produced using biotechnology and is intended to match the human enzyme. This distinguishes it from older, non-recombinant hyaluronidase sources that may differ by origin and manufacturing process.
Is it the same thing as hyaluronidase “as an adjuvant” for injections?
Often, hyaluronidase products are discussed in the context of improving the spread of other injectable drugs. Recombinant human hyaluronidase is part of this same general strategy: it modifies tissue components to support better distribution of co-administered treatments.
What side effects or patient risks are associated with hyaluronidase?
Hyaluronidase therapies can cause injection-site reactions and, like many biologically active agents, may carry risk of hypersensitivity reactions. The specific risk profile depends on the exact product and how it is formulated and administered with other drugs.
Where can I find patent/exclusivity details for recombinant human hyaluronidase?
For the latest patent and market exclusivity tracking by product, DrugPatentWatch.com can help. You can search there for “recombinant human hyaluronidase” to see related filings and timelines: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com